Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | LYPD3 |
Upstream (Parents) |
---|
(<<) EPHA2 → LYPD3 |
(<<) SLC37A1 → LYPD3 |
(<<) SERPINB5 → LYPD3 |
(<<) SPRR3 → LYPD3 |
(<<) TTC9 → LYPD3 |
Downstream (Children) |
---|
LYPD3 → MMP24 (>>) |
LYPD3 → PLXNB3 (>>) |
LYPD3 → ULBP2 (>>) |
LYPD3 → CDKN2A (>>) |
LYPD3 → PAEP (>>) |
LYPD3 → NLRP2 (>>) |
LYPD3 → CRISP1 (>>) |